glycyl-glycyl-glycine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Kim, YS; Liu, S; Liu, Z; Shi, J; Zhai, S | 1 |
| Chakraborty, S; Jia, B; Kim, YS; Liu, S; Shi, J; Wang, F; Zhou, Y | 1 |
2 other study(ies) available for glycyl-glycyl-glycine and Glioma
| Article | Year |
|---|---|
Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.
Topics: Animals; Copper Radioisotopes; Dimerization; Gene Expression Regulation, Neoplastic; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Neoplasms; Oligopeptides; Peptides, Cyclic; Polyethylene Glycols; Positron-Emission Tomography; Radiochemistry; Staining and Labeling; Tissue Distribution; Transplantation, Heterologous | 2009 |
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.
Topics: Animals; Cell Line, Tumor; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Mice; Mice, Nude; Oligopeptides; Peptides, Cyclic; Radionuclide Imaging | 2010 |